Overexpression of a conserved HSP40 chaperone reduces toxicity of several neurodegenerative disease proteins

References

• Cushman M, Johnson BS, King OD, et al. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci. 2010;123:1191–201. doi:10.1242/jcs.051672
   PubMed Web of Science ®Google Scholar
• Nonaka T, Masuda-Suzukake M, Arai T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124–34. doi:10.1016/j.celrep.2013.06.007
   PubMed Web of Science ®Google Scholar
• Nonaka T, Watanabe ST, Iwatsubo T, et al. Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem. 2010;285:34885–98. doi:10.1074/jbc.M110.148460
   PubMed Web of Science ®Google Scholar
• Johnson BS, McCaffery JM, Lindquist S, et al. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:6439–44. doi:10.1073/pnas.0802082105
   PubMed Web of Science ®Google Scholar
• Ju S, Tardiff DF, Han H, et al. A yeast model of FUS/TLS-dependent cytotoxicity. PLoS Biol. 2011;9:e1001052. doi:10.1371/journal.pbio.1001052
   PubMed Web of Science ®Google Scholar
• Khurana V, Lindquist S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? Nat Rev Neurosci. 2010;11:436–49. doi:10.1038/nrn2809
   PubMed Web of Science ®Google Scholar
• Kryndushkin D, Ihrke G, Piermartiri TC, et al. A yeast model of optineurin proteinopathy reveals a unique aggregation pattern associated with cellular toxicity. Molecular microbiology. 2012;86:1531–47. doi:10.1111/mmi.12075
   PubMed Web of Science ®Google Scholar
• Kryndushkin D, Shewmaker F. Modeling ALS and FTLD proteinopathies in yeast: an efficient approach for studying protein aggregation and toxicity. Prion. 2011;5:250–7. doi:10.4161/pri.17229
   PubMed Web of Science ®Google Scholar
• Meriin AB, Zhang X, He X, et al. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol. 2002;157:997–1004. doi:10.1083/jcb.200112104
   PubMed Web of Science ®Google Scholar
• Osherovich LZ, Weissman JS. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell. 2001;106:183–94. doi:10.1016/S0092-8674(01)00440-8
   PubMed Web of Science ®Google Scholar
• Vitrenko YA, Gracheva EO, Richmond JE, et al. Visualization of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM. J Biol Chem. 2007;282:1779–87. doi:10.1074/jbc.M609269200
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Uptain SM, Outeiro TF, et al. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:12934–9. doi:10.1073/pnas.0404968101
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Bradley ME, Hong JY, et al. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell. 2001;106:171–82. doi:10.1016/S0092-8674(01)00427-5
   PubMed Web of Science ®Google Scholar
• Du Z, Li L. Investigating the interactions of yeast prions: [SWI+], [PSI+], and [PIN+]. Genetics. 2014;197:685–700. doi:10.1534/genetics.114.163402
   PubMed Web of Science ®Google Scholar
• Bonini NM, Gitler AD. Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS. Journal of molecular neuroscience: MN. 2011;45:676–83. doi:10.1007/s12031-011-9548-9
   PubMed Web of Science ®Google Scholar
• Treusch S, Hamamichi S, Goodman JL, et al. Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science. 2011;334:1241–5. doi:10.1126/science.1213210
   PubMed Web of Science ®Google Scholar
• Couthouis J, Hart MP, Erion R, et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet. 2012;21:2899–911. doi:10.1093/hmg/dds116
   PubMed Web of Science ®Google Scholar
• Couthouis J, Hart MP, Shorter J, et al. A yeast functional screen predicts new candidate ALS disease genes. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:20881–90. doi:10.1073/pnas.1109434108
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim HJ, Hart MP, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75. doi:10.1038/nature09320
   PubMed Web of Science ®Google Scholar
• Tardiff DF, Jui NT, Khurana V, et al. Yeast reveal a “druggable” Rsp5/Nedd4 network that ameliorates alpha-synuclein toxicity in neurons. Science. 2013;342:979–83. doi:10.1126/science.1245321
   PubMed Web of Science ®Google Scholar
• Auburger G, Sen NE, Meierhofer D, et al. Efficient Prevention of Neurodegenerative Diseases by Depletion of Starvation Response Factor Ataxin-2. Trends Neurosci. 2017;40:507–16. doi:10.1016/j.tins.2017.06.004
   PubMed Web of Science ®Google Scholar
• Becker LA, Huang B, Bieri G, et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367–71. doi:10.1038/nature22038
   PubMed Web of Science ®Google Scholar
• Gitler AD, Dhillon P, Shorter J. Neurodegenerative disease: models, mechanisms, and a new hope. Dis Models Mech. 2017;10:499–502. doi:10.1242/dmm.030205
   PubMed Web of Science ®Google Scholar
• Sproviero W, Shatunov A, Stahl D, et al. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging. 2017;51:178. e1- e9. doi:10.1016/j.neurobiolaging.2016.11.010
   PubMed Web of Science ®Google Scholar
• King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61–80. doi:10.1016/j.brainres.2012.01.016
   PubMed Web of Science ®Google Scholar
• Neumann M, Kwong LK, Sampathu DM, et al. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Archives of neurology. 2007;64:1388–94. doi:10.1001/archneur.64.10.1388
   PubMed Web of Science ®Google Scholar
• Gitler ADaEAC. Modulators of TDP-43 Mediated Toxicity and Methods of Use Thereof for Identifying Agents Having Efficacy for the Treatment and Prevention of Proteinopathies. USA, 2012.
   Google Scholar
• Sun Z, Diaz Z, Fang X, et al. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi:10.1371/journal.pbio.1000614
   PubMed Web of Science ®Google Scholar
• Park SH, Kukushkin Y, Gupta R, et al. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell. 2013;154:134–45. doi:10.1016/j.cell.2013.06.003
   PubMed Web of Science ®Google Scholar
• Yang Z, Stone DE, Liebman SW. Prion promoted phosphorylation of heterologous amyloid is coupled with ubiquitin-proteasome system inhibition and toxicity. Mol Microbiol. 2014; doi:10.1111/mmi.12716
   Web of Science ®Google Scholar
• Park SK, Hong JY, Arslan F, et al. Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis. PLoS Genet. 2017;13:e1006805. doi:10.1371/journal.pgen.1006805
   PubMed Web of Science ®Google Scholar
• Udan M, Baloh RH. Implications of the prion-related Q/N domains in TDP-43 and FUS. Prion. 2011;5:1–5. doi:10.4161/pri.5.1.14265
   PubMed Web of Science ®Google Scholar
• Lee SJ, Lim HS, Masliah E, et al. Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci Res. 2011;70:339–48. doi:10.1016/j.neures.2011.05.008
   PubMed Web of Science ®Google Scholar
• Taneja V, Maddelein ML, Talarek N, et al. A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol Cell. 2007;27:67–77. doi:10.1016/j.molcel.2007.05.027
   PubMed Web of Science ®Google Scholar
• Sondheimer N, Lopez N, Craig EA, et al. The role of Sis1 in the maintenance of the [RNQ+] prion. EMBO J. 2001;20:2435–42. doi:10.1093/emboj/20.10.2435
   PubMed Web of Science ®Google Scholar
• Liebman SW, Chernoff YO. Prions in yeast. Genetics. 2012;191:1041–72. doi:10.1534/genetics.111.137760
   PubMed Web of Science ®Google Scholar